Jiyeon Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jiyeon Choi has a total of 828 co-authors. Here are the top co-authors by number of shared publications:
- Tongwu Zhang
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA
21 shared publications - Kevin M. Brown
Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
19 shared publications Nathaniel Rothman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA
15 shared publications- Maria Teresa Landi
National Cancer Institute, NIH
14 shared publications - Stephen J. Chanock
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health , Bethesda, MD
12 shared publications - Jianxin Shi
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA
11 shared publications
Latest Publications
- 11 August 2026
- Published by Springer Nature in Nature
- Vol. 656 (8129) , E48
Author Correction: Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma
- 11 August 2026
- Published by Springer Nature in Nature
- Vol. 656 (8129) , E48
Author Correction: Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma
- Open Access
- 6 May 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 15
Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8
Genome-wide association studies (GWAS) of melanoma have identified numerous susceptibility loci. However, causal genes and variants underlying risk have yet to be established for most. It is becoming apparent that many functional variants underlying complex traits act via cis-regulation that may be context-specific, dependent on availability of specific transcription factors/complexes in specific cell types and cell-states. To characterize a risk locus on chromosome band 2q33.1 associated with melanoma, breast cancer, and keratinocyte cancers, we integrated fine-mapping, cell-type specific expression quantitative trait locus (eQTL) analysis, a massively parallel reporter assay, individual luciferase assays, and SNP-based proteomics. Integrated analysis implicates the presence of multiple functional variants lying primarily within a promoter for CASP8. A haplotype containing rs3769823 appeared have the largest effect on expression. Strikingly, both tumor/normal context and this risk-associated haplotype play critical roles in mediating allelic cis-regulatory activity. Quantitative mass spectrometry for rs3769823 identified both E4F1, a transcriptional repressor, and IRF2, a transcriptional activator, as binding preferentially to risk-associated rs3969823-A. The binding of these transcription factors was validated via EMSA, supershift, and chromatin immunoprecipitation (ChIP) assays. The relative levels of E4F1 and IRF2 differ by cell-type and play a role in mediating transcriptional activity in a cell-type specific manner. Our results indicate that the top credible causal set variant rs3769823 likely influences expression of CASP8 and FLACC1 in a cell-type specific manner and may be a relevant functional variant for multiple cancers associated with this locus.
- 6 May 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 15
Open AccessFunctional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8
Genome-wide association studies (GWAS) of melanoma have identified numerous susceptibility loci. However, causal genes and variants underlying risk have yet to be established for most. It is becoming apparent that many functional variants underlying complex traits act via cis-regulation that may be context-specific, dependent on availability of specific transcription factors/complexes in specific cell types and cell-states. To characterize a risk locus on chromosome band 2q33.1 associated with melanoma, breast cancer, and keratinocyte cancers, we integrated fine-mapping, cell-type specific expression quantitative trait locus (eQTL) analysis, a massively parallel reporter assay, individual luciferase assays, and SNP-based proteomics. Integrated analysis implicates the presence of multiple functional variants lying primarily within a promoter for CASP8. A haplotype containing rs3769823 appeared have the largest effect on expression. Strikingly, both tumor/normal context and this risk-associated haplotype play critical roles in mediating allelic cis-regulatory activity. Quantitative mass spectrometry for rs3769823 identified both E4F1, a transcriptional repressor, and IRF2, a transcriptional activator, as binding preferentially to risk-associated rs3969823-A. The binding of these transcription factors was validated via EMSA, supershift, and chromatin immunoprecipitation (ChIP) assays. The relative levels of E4F1 and IRF2 differ by cell-type and play a role in mediating transcriptional activity in a cell-type specific manner. Our results indicate that the top credible causal set variant rs3769823 likely influences expression of CASP8 and FLACC1 in a cell-type specific manner and may be a relevant functional variant for multiple cancers associated with this locus.
- Open Access
Cross-ancestry proteome-wide Mendelian randomization of plasma proteins and breast cancer susceptibility
Background: The plasma proteome may help connect inherited breast cancer susceptibility to biologically interpretable and potentially actionable pathways, but proteome-wide evidence across ancestries remains limited. Methods: We conducted proteome-wide Mendelian randomization (MR) analyses of breast cancer risk using cis -protein quantitative trait loci for 1,962 distinct plasma proteins from 34,557 European-ancestry participants in the UK Biobank Pharma Proteomics Project. Breast cancer genome-wide association studies included 156,901 cases and 204,634 controls of European, East Asian, and African ancestries. Ancestry-specific MR estimates were combined by fixed-effects meta-analysis. Candidate proteins were further evaluated through subtype-specific and reverse-direction MR analyses, statistical colocalization, replication in independent European and East Asian proteomic datasets, and analyses of associations between protein polygenic scores and breast cancer status in All of Us. Results: Twelve proteins achieved Bonferroni significance in the cross-ancestry meta-analysis ( P < 0.05/1,971 tests), including eight previously reported proteins and four newly prioritized by MR. DNPH1 showed cross-ancestry heterogeneity, while CASP8, RALB, and USP28 showed cross-subtype heterogeneity after accounting for shared controls (all P < 0.05/12). Complementary support varied: six candidates showed strong colocalization (PPH4 ≥ 0.80); four replicated with a consistent direction and nominal significance in deCODE, two in the Japan COVID-19 Task Force, and four in All of Us (all P < 0.05). The strongest cumulative support was observed for LRRC25, PARK7, and LRRC37A2. Conclusions: These findings prioritize circulating protein candidates for mechanistic, prevention-oriented, and translational follow-up in breast cancer, while underscoring the need for larger ancestrally diverse proteomic resources to support equitable target and biomarker discovery.
Open AccessCross-ancestry proteome-wide Mendelian randomization of plasma proteins and breast cancer susceptibility
Background: The plasma proteome may help connect inherited breast cancer susceptibility to biologically interpretable and potentially actionable pathways, but proteome-wide evidence across ancestries remains limited. Methods: We conducted proteome-wide Mendelian randomization (MR) analyses of breast cancer risk using cis -protein quantitative trait loci for 1,962 distinct plasma proteins from 34,557 European-ancestry participants in the UK Biobank Pharma Proteomics Project. Breast cancer genome-wide association studies included 156,901 cases and 204,634 controls of European, East Asian, and African ancestries. Ancestry-specific MR estimates were combined by fixed-effects meta-analysis. Candidate proteins were further evaluated through subtype-specific and reverse-direction MR analyses, statistical colocalization, replication in independent European and East Asian proteomic datasets, and analyses of associations between protein polygenic scores and breast cancer status in All of Us. Results: Twelve proteins achieved Bonferroni significance in the cross-ancestry meta-analysis ( P < 0.05/1,971 tests), including eight previously reported proteins and four newly prioritized by MR. DNPH1 showed cross-ancestry heterogeneity, while CASP8, RALB, and USP28 showed cross-subtype heterogeneity after accounting for shared controls (all P < 0.05/12). Complementary support varied: six candidates showed strong colocalization (PPH4 ≥ 0.80); four replicated with a consistent direction and nominal significance in deCODE, two in the Japan COVID-19 Task Force, and four in All of Us (all P < 0.05). The strongest cumulative support was observed for LRRC25, PARK7, and LRRC37A2. Conclusions: These findings prioritize circulating protein candidates for mechanistic, prevention-oriented, and translational follow-up in breast cancer, while underscoring the need for larger ancestrally diverse proteomic resources to support equitable target and biomarker discovery.
- 9 April 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (9) , 1741-1752
Identification of immune cell type–specific susceptibility genes in multiple cancers using transcriptome-wide association studies
Background: Transcriptome-wide association studies (TWAS) integrate gene expression and genome-wide association studies (GWAS) to identify disease susceptibility genes. Because gene expression varies substantially across cell types within tissues, cell type–specific prediction models may enhance the power of TWAS. Methods: We conducted cell type–specific TWAS leveraging single-cell RNA sequencing data from the OneK1K cohort (14 immune cell types, 1.27 million cells) and GWAS summary statistics for 7 cancers (>290 000 cases in total). To improve prediction accuracy, we developed a modeling framework that incorporates shared gene expression effects across cell types. Results: At a false discovery rate of 5%, we identified 106 (Bonferroni 5%: 13) previously unreported loci for breast cancer, 51 (4) loci for prostate cancer, 11 (4) loci for lung cancer, 39 (5) loci for melanoma, 9 (1) loci for ovarian cancer, and 2 (1) loci for diffuse large B-cell lymphoma, with most genes exhibiting cell type specificity. Gene set analyses confirmed joint associations of unreported genes with breast and prostate cancer risk in UK Biobank data. Additional lung tissue single-cell RNA sequencing data with 113 individuals validated 18 of 32 (56.3%) statistically significant genes for lung cancer. Across cancers, 139 statistically significant genes were shared by at least 2 cancer types and were primarily enriched in specific immune cell types. Conclusion: Cell type–specific TWAS improve the identification of novel cancer susceptibility loci and provide insights into the immune landscape of cancer etiology.
- 9 April 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (9) , 1741-1752
Identification of immune cell type–specific susceptibility genes in multiple cancers using transcriptome-wide association studies
Background: Transcriptome-wide association studies (TWAS) integrate gene expression and genome-wide association studies (GWAS) to identify disease susceptibility genes. Because gene expression varies substantially across cell types within tissues, cell type–specific prediction models may enhance the power of TWAS. Methods: We conducted cell type–specific TWAS leveraging single-cell RNA sequencing data from the OneK1K cohort (14 immune cell types, 1.27 million cells) and GWAS summary statistics for 7 cancers (>290 000 cases in total). To improve prediction accuracy, we developed a modeling framework that incorporates shared gene expression effects across cell types. Results: At a false discovery rate of 5%, we identified 106 (Bonferroni 5%: 13) previously unreported loci for breast cancer, 51 (4) loci for prostate cancer, 11 (4) loci for lung cancer, 39 (5) loci for melanoma, 9 (1) loci for ovarian cancer, and 2 (1) loci for diffuse large B-cell lymphoma, with most genes exhibiting cell type specificity. Gene set analyses confirmed joint associations of unreported genes with breast and prostate cancer risk in UK Biobank data. Additional lung tissue single-cell RNA sequencing data with 113 individuals validated 18 of 32 (56.3%) statistically significant genes for lung cancer. Across cancers, 139 statistically significant genes were shared by at least 2 cancer types and were primarily enriched in specific immune cell types. Conclusion: Cell type–specific TWAS improve the identification of novel cancer susceptibility loci and provide insights into the immune landscape of cancer etiology.
- Open Access
Single-cell full-length transcriptome of human lung reveals genetic effects on isoform regulation beyond gene-level expression
Genetic regulation of splicing uniquely contributes to trait-associated genome-wide association studies (GWAS) signals. However, quantitative trait loci (QTL) analysis using short-read sequencing of bulk tissues fails to capture full-length and cell-type-specific isoforms. Here, we present an isoform-level lung cell atlas from 129 never-smoking Korean women using single-cell long-read RNA-sequencing, identifying abundant unannotated and cell-type-specific isoforms. Isoform-level signatures of 37 lung cell types display a larger difference and therefore improve cell-type classification compared to gene-level expression. Notably, isoform-QTLs (isoQTLs) detect unannotated and/or cell-type-specific isoforms with independent genetic regulation from expression-QTL (eQTL), supported by enriched splicing functional elements. IsoQTLs nominate susceptibility isoforms from previously unexplained lung function and cancer GWAS loci, via eQTL-independent signals. We highlight a potentially functional novel variant of PPIL6 in multiciliated cells underlying lung cancer risk through alternative splicing. This isoform-level resource advances our understanding of cell-type-specific isoform regulation and its contribution to lung traits and diseases.
Open AccessSingle-cell full-length transcriptome of human lung reveals genetic effects on isoform regulation beyond gene-level expression
Genetic regulation of splicing uniquely contributes to trait-associated genome-wide association studies (GWAS) signals. However, quantitative trait loci (QTL) analysis using short-read sequencing of bulk tissues fails to capture full-length and cell-type-specific isoforms. Here, we present an isoform-level lung cell atlas from 129 never-smoking Korean women using single-cell long-read RNA-sequencing, identifying abundant unannotated and cell-type-specific isoforms. Isoform-level signatures of 37 lung cell types display a larger difference and therefore improve cell-type classification compared to gene-level expression. Notably, isoform-QTLs (isoQTLs) detect unannotated and/or cell-type-specific isoforms with independent genetic regulation from expression-QTL (eQTL), supported by enriched splicing functional elements. IsoQTLs nominate susceptibility isoforms from previously unexplained lung function and cancer GWAS loci, via eQTL-independent signals. We highlight a potentially functional novel variant of PPIL6 in multiciliated cells underlying lung cancer risk through alternative splicing. This isoform-level resource advances our understanding of cell-type-specific isoform regulation and its contribution to lung traits and diseases.
- Open Access
Single-cell lung eQTL dataset of Asian never-smokers highlights the roles of alveolar cells in lung cancer etiology
Single-cell expression quantitative trait loci (sc-eQTL) analyses are powerful in identifying context-specific susceptibility genes from genome-wide association studies (GWAS) loci. However, few studies have comprehensively investigated cells of lung cancer origin in non-European populations. Here, we built a lung sc-eQTL dataset from 129 Korean women never-smokers with epithelial cell enrichment. eQTL mapping identified 2,229 genes with an eQTL in 33 cell types, including East Asian-specific findings when compared to predominantly European datasets. Integration with single-cell chromatin accessibility data demonstrated an enrichment of cell-type specific eQTLs in cell-type matched candidate enhancers, while shared eQTLs were more frequently found near promoters. Colocalization and transcriptome-wide association study unveiled 36 susceptibility genes from 22 cell types in 22 lung cancer loci, including 10 loci not achieving genome-wide significance in prior GWAS. Around 47% of these genes were from cells of the alveoli, underscoring their importance, especially in lung adenocarcinoma (LUAD) susceptibility. Focusing on the trajectory of alveolar epithelial cell regeneration, we detected 785 cell-state-interacting QTLs, which overlapped with 28% (10) of the identified susceptibility genes. Finally, we experimentally validated East Asian-and alveolar type 2 cell-specific eQTL of TCF7L2 underlying East Asian LUAD locus, 10q25.2. Consistent with its role as a Wnt/β-catenin effector, TCF7L2 displayed significant effect on lung adenocarcinoma cell growth. Our data highlighted context-specific susceptibility genes, especially from alveolar cells of lung, contributing to lung cancer etiology.
Open AccessSingle-cell lung eQTL dataset of Asian never-smokers highlights the roles of alveolar cells in lung cancer etiology
Single-cell expression quantitative trait loci (sc-eQTL) analyses are powerful in identifying context-specific susceptibility genes from genome-wide association studies (GWAS) loci. However, few studies have comprehensively investigated cells of lung cancer origin in non-European populations. Here, we built a lung sc-eQTL dataset from 129 Korean women never-smokers with epithelial cell enrichment. eQTL mapping identified 2,229 genes with an eQTL in 33 cell types, including East Asian-specific findings when compared to predominantly European datasets. Integration with single-cell chromatin accessibility data demonstrated an enrichment of cell-type specific eQTLs in cell-type matched candidate enhancers, while shared eQTLs were more frequently found near promoters. Colocalization and transcriptome-wide association study unveiled 36 susceptibility genes from 22 cell types in 22 lung cancer loci, including 10 loci not achieving genome-wide significance in prior GWAS. Around 47% of these genes were from cells of the alveoli, underscoring their importance, especially in lung adenocarcinoma (LUAD) susceptibility. Focusing on the trajectory of alveolar epithelial cell regeneration, we detected 785 cell-state-interacting QTLs, which overlapped with 28% (10) of the identified susceptibility genes. Finally, we experimentally validated East Asian-and alveolar type 2 cell-specific eQTL of TCF7L2 underlying East Asian LUAD locus, 10q25.2. Consistent with its role as a Wnt/β-catenin effector, TCF7L2 displayed significant effect on lung adenocarcinoma cell growth. Our data highlighted context-specific susceptibility genes, especially from alveolar cells of lung, contributing to lung cancer etiology.
- 10 March 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (7) , 1299-1312
Methylation signatures distinguish non-small cell lung cancer subtypes and are associated with survival in smokers with lung squamous cell carcinoma
Introduction: Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are the 2 major histologic subtypes of non-small cell lung cancer and differ in prognosis, biological behavior, and molecular characteristics. Although aberrant DNA methylation has been implicated in lung cancer and patient survival, systematic investigations of subtype-specific methylation signatures distinguishing these subtypes remain limited. Methods: We identified DNA methylation signatures that distinguish LUSC from LUAD and evaluated their associations with survival among ever-smokers using data from The Cancer Genome Atlas, with independent validation in the CURELUNG cohort. Survival analyses assessed associations between a methylation-based score and patient survival. Integrative analyses incorporating mRNA expression, global proteomic profiles, and transcription factor (TF) motifs enrichment were performed to explore potential regulatory features associated with the identified methylation markers. Results: Eleven differentially methylated CpG sites distinguished LUSC and LUAD and demonstrated high classification accuracy in an independent validation cohort. Among LUSC cases, lower methylation scores (below the median) were associated with a 2.7-fold increased risk of mortality during the first 2 years of follow-up based on piecewise Cox regression models. Integrative analyses revealed subtype-specific differences in CALML3 expression and enrichment of TF binding motifs near the identified signatures, particularly C2H2 zinc-finger motifs. Conclusion: This study identified a subtype-specific DNA methylation signature that robustly distinguishes LUAD and LUSC and is associated with early survival among ever-smokers with LUSC. These findings highlight biologically meaningful epigenetic patterns that may contribute to histology-specific tumor behavior and provide a foundation for future mechanistic and biomarker development studies.
- 10 March 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (7) , 1299-1312
Methylation signatures distinguish non-small cell lung cancer subtypes and are associated with survival in smokers with lung squamous cell carcinoma
Introduction: Lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) are the 2 major histologic subtypes of non-small cell lung cancer and differ in prognosis, biological behavior, and molecular characteristics. Although aberrant DNA methylation has been implicated in lung cancer and patient survival, systematic investigations of subtype-specific methylation signatures distinguishing these subtypes remain limited. Methods: We identified DNA methylation signatures that distinguish LUSC from LUAD and evaluated their associations with survival among ever-smokers using data from The Cancer Genome Atlas, with independent validation in the CURELUNG cohort. Survival analyses assessed associations between a methylation-based score and patient survival. Integrative analyses incorporating mRNA expression, global proteomic profiles, and transcription factor (TF) motifs enrichment were performed to explore potential regulatory features associated with the identified methylation markers. Results: Eleven differentially methylated CpG sites distinguished LUSC and LUAD and demonstrated high classification accuracy in an independent validation cohort. Among LUSC cases, lower methylation scores (below the median) were associated with a 2.7-fold increased risk of mortality during the first 2 years of follow-up based on piecewise Cox regression models. Integrative analyses revealed subtype-specific differences in CALML3 expression and enrichment of TF binding motifs near the identified signatures, particularly C2H2 zinc-finger motifs. Conclusion: This study identified a subtype-specific DNA methylation signature that robustly distinguishes LUAD and LUSC and is associated with early survival among ever-smokers with LUSC. These findings highlight biologically meaningful epigenetic patterns that may contribute to histology-specific tumor behavior and provide a foundation for future mechanistic and biomarker development studies.
- Open Access
Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus
Chromosome 5p15.33 harbors several independent association signals which demonstrate antagonistic pleiotropy across cancer types, with causal mechanisms largely unresolved. To identify functional variants and enhancer elements at this locus, we performed statistical fine-mapping followed by massively parallel reporter assays (MPRA) and proliferation based CRISPRi screens. This approach identified eight multi-cancer functional variants (MCFVs) across three GWAS signals. Targeting rs421629 (part of the CLPTM1L signal marked by rs465498) with CRISPRi revealed opposing effects on TERT expression in pancreatic versus lung cancer cells, consistent with the antagonistic pleiotropy observed for this signal. Furthermore, CRISPRi nominated an intronic CLPTM1L variable number tandem repeat (VNTR) as a potent enhancer. Long-read sequencing established VNTR polymorphisms as potential causal variants for the rs465498 signal. We showed that Hippo-pathway transcription factors mediate VNTR enhancer activity in lung and pancreatic cancer cells. Together, these findings indicate that cancer susceptibility at 5p15.33 may be mediated by both SNPs and VNTRs and provide an integrated framework for resolving complex pleiotropic loci.
Open AccessIntegrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus
Chromosome 5p15.33 harbors several independent association signals which demonstrate antagonistic pleiotropy across cancer types, with causal mechanisms largely unresolved. To identify functional variants and enhancer elements at this locus, we performed statistical fine-mapping followed by massively parallel reporter assays (MPRA) and proliferation based CRISPRi screens. This approach identified eight multi-cancer functional variants (MCFVs) across three GWAS signals. Targeting rs421629 (part of the CLPTM1L signal marked by rs465498) with CRISPRi revealed opposing effects on TERT expression in pancreatic versus lung cancer cells, consistent with the antagonistic pleiotropy observed for this signal. Furthermore, CRISPRi nominated an intronic CLPTM1L variable number tandem repeat (VNTR) as a potent enhancer. Long-read sequencing established VNTR polymorphisms as potential causal variants for the rs465498 signal. We showed that Hippo-pathway transcription factors mediate VNTR enhancer activity in lung and pancreatic cancer cells. Together, these findings indicate that cancer susceptibility at 5p15.33 may be mediated by both SNPs and VNTRs and provide an integrated framework for resolving complex pleiotropic loci.
- Open Access
- 24 January 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (6) , 1032-1045
Identifying expression and DNA methylation biomarkers for lung adenocarcinoma risk in East Asia
Background: Lung adenocarcinoma (LUAD) is the most common type of lung cancer. A recent genome-wide association study of lung adenocarcinoma in East Asia reported 28 independent susceptibility variants across 25 loci and identified 2 genes whose genetically predicted expression levels are associated with lung adenocarcinoma risk, using an ancestry-matched lung tissue expression quantitative trait loci (QTL) dataset. It is desirable to identify additional susceptibility loci and to understand their underlying biological mechanisms. Methods: Using an expanded genome-wide association study of lung adenocarcinoma in East Asia and ancestry-matched lung tissue expression QTL and DNA methylation QTL datasets, we performed transcriptome-wide association studies and DNA methylome-wide association studies simultaneously and examined the association between measured expression of genes and DNA methylation of nearby CpGs. Genes and nearby CpGs are termed CpG–gene–LUAD trios if these 3 associations hold simultaneously. Results: At a Bonferroni-corrected P value less than .05, we identified a new susceptibility locus (6p21.31; lead single-nucleotide polymorphism rs7772643), 10 lung adenocarcinoma–associated genes, and 86 lung adenocarcinoma–associated CpGs. At a false discovery rate q value less than 0.05, we identified 28 lung adenocarcinoma–associated genes, 220 lung adenocarcinoma–associated CpGs, and 45 CpG–gene–LUAD trios; among them, 43 were direction-matched regarding these 3 associations. These show that 23 of the known 28 susceptibility variants for lung adenocarcinoma in East Asia are near these genes or CpGs and MARCH3, ELF5, IKZF3, GSDMB, CCDC116, and DSP are putative novel candidate genes. Few of them were reported in lung adenocarcinoma in European populations. Conclusions: This study substantially advances our understanding of the etiology of lung adenocarcinoma in East Asia and could be useful in developing translational applications.
- 24 January 2026
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 118 (6) , 1032-1045
Open AccessIdentifying expression and DNA methylation biomarkers for lung adenocarcinoma risk in East Asia
Background: Lung adenocarcinoma (LUAD) is the most common type of lung cancer. A recent genome-wide association study of lung adenocarcinoma in East Asia reported 28 independent susceptibility variants across 25 loci and identified 2 genes whose genetically predicted expression levels are associated with lung adenocarcinoma risk, using an ancestry-matched lung tissue expression quantitative trait loci (QTL) dataset. It is desirable to identify additional susceptibility loci and to understand their underlying biological mechanisms. Methods: Using an expanded genome-wide association study of lung adenocarcinoma in East Asia and ancestry-matched lung tissue expression QTL and DNA methylation QTL datasets, we performed transcriptome-wide association studies and DNA methylome-wide association studies simultaneously and examined the association between measured expression of genes and DNA methylation of nearby CpGs. Genes and nearby CpGs are termed CpG–gene–LUAD trios if these 3 associations hold simultaneously. Results: At a Bonferroni-corrected P value less than .05, we identified a new susceptibility locus (6p21.31; lead single-nucleotide polymorphism rs7772643), 10 lung adenocarcinoma–associated genes, and 86 lung adenocarcinoma–associated CpGs. At a false discovery rate q value less than 0.05, we identified 28 lung adenocarcinoma–associated genes, 220 lung adenocarcinoma–associated CpGs, and 45 CpG–gene–LUAD trios; among them, 43 were direction-matched regarding these 3 associations. These show that 23 of the known 28 susceptibility variants for lung adenocarcinoma in East Asia are near these genes or CpGs and MARCH3, ELF5, IKZF3, GSDMB, CCDC116, and DSP are putative novel candidate genes. Few of them were reported in lung adenocarcinoma in European populations. Conclusions: This study substantially advances our understanding of the etiology of lung adenocarcinoma in East Asia and could be useful in developing translational applications.
- Open Access
Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8
Genome-wide association studies (GWAS) of melanoma have identified numerous susceptibility loci. However, causal genes and variants underlying risk have yet to be established for most. It is becoming apparent that many functional variants underlying complex traits act via cis -regulation that may be context-specific, dependent on availability of specific transcription factors/complexes in specific cell types and cell-states. To characterize a risk locus on chromosome band 2q33.1 associated with melanoma, breast cancer, and keratinocyte cancers, we integrated fine-mapping, cell-type specific expression quantitative trait locus (eQTL) analysis, a massively parallel reporter assay, individual luciferase assays, and SNP-based proteomics. Integrated analysis implicates the presence of multiple functional variants lying primarily within a promoter for CASP8 . A haplotype containing rs3769823 appeared have the largest effect on expression. Strikingly, both tumor/normal context and this risk-associated haplotype play critical roles in mediating allelic cis -regulatory activity. Quantitative mass spectrometry for rs3769823 identified both E4F1, a transcriptional repressor, and IRF2, a transcriptional activator, as binding preferentially to risk-associated rs3969823-A. The binding of these transcription factors was validated via EMSA, supershift, and chromatin immunoprecipitation (ChIP) assays. The relative levels of E4F1 and IRF2 differ by cell-type and play a role in mediating transcriptional activity in a cell-type specific manner. Our results indicate that the top credible causal set variant rs3769823 likely influences expression of CASP8 and FLACC1 in a cell-type specific manner and may be a relevant functional variant for multiple cancers associated with this locus.
Open AccessFunctional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8
Genome-wide association studies (GWAS) of melanoma have identified numerous susceptibility loci. However, causal genes and variants underlying risk have yet to be established for most. It is becoming apparent that many functional variants underlying complex traits act via cis -regulation that may be context-specific, dependent on availability of specific transcription factors/complexes in specific cell types and cell-states. To characterize a risk locus on chromosome band 2q33.1 associated with melanoma, breast cancer, and keratinocyte cancers, we integrated fine-mapping, cell-type specific expression quantitative trait locus (eQTL) analysis, a massively parallel reporter assay, individual luciferase assays, and SNP-based proteomics. Integrated analysis implicates the presence of multiple functional variants lying primarily within a promoter for CASP8 . A haplotype containing rs3769823 appeared have the largest effect on expression. Strikingly, both tumor/normal context and this risk-associated haplotype play critical roles in mediating allelic cis -regulatory activity. Quantitative mass spectrometry for rs3769823 identified both E4F1, a transcriptional repressor, and IRF2, a transcriptional activator, as binding preferentially to risk-associated rs3969823-A. The binding of these transcription factors was validated via EMSA, supershift, and chromatin immunoprecipitation (ChIP) assays. The relative levels of E4F1 and IRF2 differ by cell-type and play a role in mediating transcriptional activity in a cell-type specific manner. Our results indicate that the top credible causal set variant rs3769823 likely influences expression of CASP8 and FLACC1 in a cell-type specific manner and may be a relevant functional variant for multiple cancers associated with this locus.